|Related CPTech Pages|
|Generic Drugs and Pricing|
|U.S. Patent Extentions|
|Lawsuits Relating to the "Evergreening" of Patents|
"Generic drugs substantially reduce the cost of purchasing pharmaceuticals by typically offering price discounts from 50% to 75%."
"The biggest difference between a generic drug and its brand name counterpart is usually price. A generic drug may be priced anywhere between 20 percent and 75 percent of the cost of the brand name version."
|Generic Approval Times|
The lawsuit charges that "...in exchange for a bribe of $40 million per year from Hoechst, Andrx has entered into an agreement in restraint of trade with Hoechst to not sell its FDA-approved generic version of Cardizem CD in the United States.The lawsuit alleges that the purpose of the conspiracy between Hoechst and Andrx is to prevent any generic Cardizem CD from reaching the United States market, depriving all purchasers, including hypertension and angina sufferers, of the ability to purchase the drug at a fair price, thereby enabling Hoechst to maintain their dominance over once-a-day diltiazen, which lets them fix the price of Cardizem CD without competition.Apparently the FTC is also involved. (Reported by USA Today).
The illegal activity allowed Mylan to dramatically increase the price of the two drugs used by millions of Americans, the Commission alleged. In January of this year, the company raised the wholesale price of clorazepate from $11.36 to approximately $377.00 per bottle of 500 tablets. And, in March, the wholesale price of lorazepam went from $7.30 for a bottle of 500 tablets to approximately $190.00